Editor,—Tunç et alpublished a thorough analysis of the course and management of orbital lymphangiomas. They state that besides careful and sometimes repeated surgery there is little convincing evidence of other promising treatment options: “ . . .few patients have been treated with other modalities including . . .sclerosing agents but there are sparse data with those approaches”.1 The latter fact might be the result of failures, which have not been published. Therefore, we would like to communicate …